Inhibition of Bruton's tyrosine kinase with PD-1 blockade modulates T cell activation in solid tumors.
Schwarz E, Benner B, Wesolowski R, Quiroga D, Good L, Sun SH, Savardekar H, Li J, Jung KJ, Duggan MC, Lapurga G, Shaffer J, Scarberry L, Konda B, Verschraegen C, Kendra K, Shah M, Rupert R, Monk P, Shah HA, Noonan AM, Bixel K, Hays J, Wei L, Pan X, Behbehani G, Hu Y, Elemento O, Chung D, Xin G, Blaser BW, Carson WE 3rd.
Schwarz E, et al. Among authors: carson we 3rd.
JCI Insight. 2024 Nov 8;9(21):e169927. doi: 10.1172/jci.insight.169927.
JCI Insight. 2024.
PMID: 39513363
Free PMC article.
Clinical Trial.